COMPARING THE EFFECTS OF ROPIVACAINE HCL WITH BUPIVACAINE HCL ON POST-OPERATIVE PAIN IN LAPAROTOMY WOUND INFILTRATION

Comparing the effects of ropivacaine HCL with bupivacaine HCL on post-operative pain in laparotomy wound infiltration

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202407493293626

Enrollment

Registered

2024-07-10

Start date

2024-07-15

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery Anaesthesia

Interventions

Wound infiltration with Ropivacaine HCL

Wound Infiltration with Bupivacaine HCL

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients between ages of 16 and 65 years Patients who have given written consent Patients scheduled for elective laparotomy ASA I and II Status Body Weights 50-75Kg (BMI: 18.5-25)

Exclusion criteria

Exclusion criteria: Known hypersensitivity to the agents Patients who required sedation postoperatively Refusal to participate in the study Patients with known hepatic disease Mute and deaf patients Patients with known chronic pain syndrome

Design outcomes

Primary

Measure	Time frame
Primary outcome measure was efficacy of ropivacaine HCL in controlling post operative pain compared to bupivacaine HCL using the NRS at 30minutes, 1hr, 6hrs, 12hrs, 24hrs and 48hrs post-operatively.	—

Secondary

Measure	Time frame
Secondary outcome measures are time to first analgesic request, total analgesic consumption, time to return of bowel function, satisfaction with pain control.	—

Countries

Nigeria

Contacts

Public ContactOyeyemi Dada

Researcher

dadaebenezer14@gmail.com+2349035783188

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026